Gerard Fischer

CEO

17 past transactions

ANYbotics

Series B in 2023
ANYbotics is a manufacturer of four-legged robots intended for a variety of industrial uses. The company enhances safety and productivity in industrial operations through autonomous mobile robots capable of navigating complex environments. It provides solutions for robot applications with the most advanced mobility and autonomy requirements in challenging terrain. ANYbotics was founded in 2016 and is headquartered in Zürich, Switzerland.

Ecorobotix

Series B in 2023
ecoRobotix Ltd develops, manufactures, and sells farming machines. It offers an autonomous machine for weeding of row crops, meadows, and intercropping cultures. The company’s system of vision enables it to follow crop rows, and to detect the presence and position of weeds in and between the rows; and the robotic arms apply a micro dose of herbicide targeting the weeds that have been detected. ecoRobotix Ltd was founded in 2011 and is based in Yverdon-les-Bains, Switzerland.

tado°

Venture Round in 2023
Tado° is The Heating App for private homes and small businesses. It adjusts to the residents' behavior in real time and also takes current weather forecasts and building characteristics into account. tado° GmbH is a Munich based Tech Startup bringing Internet of Things into the Cleantech Market. It was founded by Christian Deilmann, Johannes Schwarz, Valentin Sawadski and Leopold von Bismarck in 2011. A team of qualified young professionals has been working on the development of tado° for approximately two years in Munich.

Memo Therapeutics

Series B in 2022
Memo Therapeutics AG, based in Basel, Switzerland, specializes in antibody discovery and immune repertoire analysis through its innovative MemoMAB platform. This technology enables the creation of a recombinant in vitro copy of an individual’s B cell and antibody repertoire, resulting in unique and extensive libraries that reflect a person's immune response. These libraries are anticipated to contain a significant number of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics employs its MemoMAB platform in proprietary antibody lead discovery programs and offers it for collaboration with other entities, enhancing the potential for novel therapeutic developments.

Fotokite

Series B in 2022
Fotokite is a company focused on simplifying and securing aerial sensing through its innovative technology. Originating from ETH Zurich’s Flying Machine Arena, Fotokite systems operate autonomously for over 24 hours, delivering real-time video and sensor data to various sectors, including news and sports broadcasting, public safety, and industrial inspection. Since the launch of its first-generation products in 2016, Fotokite has garnered a diverse clientele, including major organizations such as CNN, BBC, Tribune Media, and AFP. The company aims to enhance operational capabilities and situational awareness for its users through its interactive personal flying cameras.

MedTrace Pharma

Venture Round in 2021
MedTrace Pharma A/S is a Danish company focused on enhancing medical imaging through innovative technology. Founded in 2015 and headquartered in Kongens Lyngby, with additional offices in Boston and Uppsala, the company develops an automated system for producing radioactive water, specifically 15O-water, used in positron emission tomography (PET) scans. This system, known as MT-100, automates both the bedside production and infusion of the tracer, significantly increasing the sensitivity of patient analysis and improving throughput by up to four times compared to existing methods. MedTrace also offers aQuant, an analytical software platform designed to interpret PET scan results, further advancing the accuracy and efficiency of clinical diagnostics.

Memo Therapeutics

Series B in 2020
Memo Therapeutics AG, based in Basel, Switzerland, specializes in antibody discovery and immune repertoire analysis through its innovative MemoMAB platform. This technology enables the creation of a recombinant in vitro copy of an individual’s B cell and antibody repertoire, resulting in unique and extensive libraries that reflect a person's immune response. These libraries are anticipated to contain a significant number of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics employs its MemoMAB platform in proprietary antibody lead discovery programs and offers it for collaboration with other entities, enhancing the potential for novel therapeutic developments.

Varjo

Series C in 2020
Varjo Technologies develops headset capable of both virtual and augmented reality. It uses that phrase with two meanings in mind. For one thing, the company’s headset offers resolution in the center of the screen that is good enough to hide individual pixels. But the headset’s display also mimics how human vision works in general. The high-density displays occupies the center of the field of view in headset, and surrounds by lower-resolution displays at the left and right edges. The company was founded in 2016 and is headquartered in Helsinki, Finland.

Beekeeper

Series B in 2020
Beekeeper AG is a mobile-first team communication platform designed to enhance communication within frontline and mobile workforces. Established in 2012 and headquartered in Zurich, Switzerland, with additional operations in Kraków, Berlin, and Oakland, Beekeeper provides various tools such as real-time messaging, content management, engagement analytics, and employee surveys. The platform aims to improve productivity and reduce turnover by automating workflows and offering managers insights through an analytics dashboard. Beekeeper serves a diverse range of industries, including hospitality, retail, logistics, transportation, food, manufacturing, non-governmental organizations, and event management, both in the United States and internationally. Its integration capabilities allow users to access operational systems through a centralized portal, facilitating effective communication and collaboration among internal teams.

OncoDNA

Series B in 2020
OncoDNA, with over 60 years’ expertise in medical diagnostics, was founded by a team of experts with many years of experience in DNA sequencing and diagnostic analyses in oncology.

Versantis

Series B in 2019
Versantis AG develops medicines and diagnostics for liver diseases worldwide. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic acidemia and diagnosis of hyperammonemia. Versantis AG was founded in 2015 and is based in Zurich, Switzerland.

Beekeeper

Series B in 2019
Beekeeper AG is a mobile-first team communication platform designed to enhance communication within frontline and mobile workforces. Established in 2012 and headquartered in Zurich, Switzerland, with additional operations in Kraków, Berlin, and Oakland, Beekeeper provides various tools such as real-time messaging, content management, engagement analytics, and employee surveys. The platform aims to improve productivity and reduce turnover by automating workflows and offering managers insights through an analytics dashboard. Beekeeper serves a diverse range of industries, including hospitality, retail, logistics, transportation, food, manufacturing, non-governmental organizations, and event management, both in the United States and internationally. Its integration capabilities allow users to access operational systems through a centralized portal, facilitating effective communication and collaboration among internal teams.

SWISSto12

Series B in 2019
SWISSto12 SA, founded in 2011 and based in Renens, Switzerland, specializes in manufacturing and supplying radio frequency (RF) and microwave components and systems. The company offers a variety of antenna products, including horn antennas, airborne antenna arrays, and custom-designed antennas tailored to specific needs. Additionally, SWISSto12 produces waveguide products, filters, and subsystems, employing advanced 3D printing and surface treatment techniques to enhance its offerings. The company is also engaged in developing a WebMCK software solution for material properties extraction. Its innovative manufacturing approaches aim to increase design flexibility while reducing costs, lead times, and weight of components. SWISSto12 serves markets including satellite communications, airborne satellites, and research institutions, with additional offices in Santa Clara, California, and Rehovot, Israel. The firm's name reflects its Swiss engineering heritage and expertise in terahertz signal technology.

GetYourGuide

Series E in 2019
GetYourGuide Deutschland GmbH operates an online platform for booking tours, attractions, and activities worldwide. The company offers tourist services online via the Internet and mobile applications. GetYourGuide Deutschland GmbH was founded in 2009 and is based in Berlin, Germany with additional offices in North America and Europe.

GetYourGuide

Secondary Market in 2019
GetYourGuide Deutschland GmbH operates an online platform for booking tours, attractions, and activities worldwide. The company offers tourist services online via the Internet and mobile applications. GetYourGuide Deutschland GmbH was founded in 2009 and is based in Berlin, Germany with additional offices in North America and Europe.